Nurse Practitioner · Duarte, CA
NPI
1508396557
Since 2017
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1500 Duarte Rd
Duarte, CA, 91010
Phone (626) 256-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
693 services
Medicare patients, 2024
163
Average age 72
Drug cost, 2024
$4.4M
1,470 prescriptions
Company payments, 2025
$1,313
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raymond S Hernandez was code 99215 (office e&m - established), 208 times for 58 patients. In total Raymond S Hernandez billed 693 services in 12 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 208 | 58 | $103.33 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 175 | 59 | $12.07 | $2,113 |
| 99214 Office E&M - Established | Facility | 125 | 51 | $65.22 | $8,152 |
| 38222 Other Organ Systems | Facility | 84 | 71 | $53.96 | $4,533 |
| 99213 Office E&M - Established | Facility | 57 | 41 | $44.35 | $2,528 |
| 99442 Telephone Services | Office | 24 | 15 | $63.53 | $1,525 |
By year: 2022 $39K for 528 services; 2023 $35K for 476 services; 2024 $42K for 693 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raymond S Hernandez prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 195 prescriptions and refills. In total Raymond S Hernandez wrote 1,470 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jakafi Ruxolitinib Phosphate | 195 | 195 | 28 | $2.6M |
| Acyclovir Generic | 126 | 210 | 29 | $1,476 |
| Atovaquone Generic | 111 | 116 | 19 | $49K |
| Ursodiol Generic | 71 | 106 | 19 | $4,819 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 66 | 88 | 15 | $408 |
| Pantoprazole Sodium Generic | 47 | 94 | 15 | $332 |
| Potassium Chloride Generic | 42 | 56 | 18 | $841 |
| Allopurinol Generic | 41 | 82 | 12 | $292 |
| Posaconazole Generic | 39 | 39 | 11 | $54K |
| Folic Acid Generic | 30 | 46 | Under 11 | $150 |
| Amlodipine Besylate Generic | 30 | 42 | Under 11 | $72.18 |
| Tamsulosin Hcl Generic | 27 | 43 | Under 11 | $182 |
| Prednisone Generic | 24 | 34 | Under 11 | $97.17 |
| Sirolimus Generic | 24 | 46 | Under 11 | $4,870 |
| Famotidine Generic | 22 | 32 | Under 11 | $395 |
Brand drugs: - claims; generic drugs: 1,104 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raymond S Hernandez $1,313 ($1,313 in general payments such as food, travel and fees) from 10 companies. The largest payer was PharmaEssentia USA Corporation with $452.
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation 6446.TW | 2 | $452 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $222 |
| Incyte Corporation INCY | 4 | $200 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $187 |
| Daiichi Sankyo Inc. 4568.T | 4 | $89.72 |
| Abbvie Inc. ABBV | 3 | $61 |
| GlaxoSmithKline, LLC. GSK | 1 | $29.99 |
| BeOne Medicines USA, Inc. ONC | 1 | $27.64 |
| BeiGene USA, Inc. ONC | 1 | $26.6 |
| Azurity Pharmaceuticals, Inc. | 1 | $16.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.